<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>PERMAX- pergolide tablet </strong><br>Valeant Pharmaceuticals, Inc.<br></p></div>
<h1>PERMAX<span class="Sup">®</span><br>
PERGOLIDE TABLETS, USP<br>
</h1>
<div class="Contents">
<div class="Section">
<a name="section-1"></a><p></p>
</div>
<div class="Warning">
<a name="A36516FE-5ABA-405E-A489-0CA83129C698"></a><a name="section-2"></a><p></p>
<h1>WARNING</h1>
<p class="First"><span class="Bold Italics"><span class="product-label-link" type="condition" conceptid="4281749" conceptname="Heart valve disorder">Cardiac Valvulopathy</span> and Fibrotic Complications</span></p>
<p><span class="Bold"><span class="product-label-link" type="condition" conceptid="4281749" conceptname="Heart valve disorder">Cardiac Valvulopathy</span></span></p>
<p><span class="Bold">The use of pergolide has been shown to increase the risk of cardiac valvular disease involving one or more valves.  Some patients have required valve replacement, and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">deaths</span> have been reported. Cases have been reported after exposures to pergolide ranging from several months to several years.  The histopathology of explanted valves is similar to that of other drug-induced valvulopathies. Precise risk estimates of pergolide-induced cardiac valvular disease are not available. </span></p>
<p><span class="Bold">Specific risk factors predisposing patients to developing cardiac valvular disease with pergolide have not been identified.  <span class="product-label-link" type="condition" conceptid="4281749" conceptname="Heart valve disorder">Cardiac valvulopathy</span> has been reported with all doses of pergolide; however, available data suggest that the risk may be greater with higher doses.  Doses of pergolide above 5 mg/day are not recommended (</span><span class="Bold Italics">see</span><a href="#A7F1360A-3D0D-49A0-93E8-FD0BEDE6837B">DOSAGE &amp; ADMINISTRATION</a><span class="Bold">).</span></p>
<p><span class="Bold">Pergolide is not recommended for use in patients with a history of <span class="product-label-link" type="condition" conceptid="4281749" conceptname="Heart valve disorder">cardiac valvulopathy</span>.</span></p>
<p><span class="Bold">Before initiating treatment with pergolide, all patients should undergo a cardiovascular evaluation, including an echocardiogram, to determine whether valvular disease is present and to provide a baseline for subsequent monitoring.  Although the risk of disease progression in patients with asymptomatic valvular disease is unknown, pergolide ordinarily should not be initiated if valvulopathy is detected at screening. </span></p>
<p><span class="Bold">All patients taking pergolide should undergo periodic echocardiograms to screen for the development of valvulopathy. Patients should also be monitored for signs and symptoms of valvulopathy, including <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span>, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span> and new <span class="product-label-link" type="condition" conceptid="316822" conceptname="Heart murmur">cardiac murmurs</span>. If a patient develops these signs or symptoms, consideration should be given to suspending treatment with pergolide until a full diagnostic evaluation, including echocardiogram, has been performed. Pergolide should ordinarily be discontinued if a patient is diagnosed with cardiac valvular disease. In some cases, signs and/or symptoms of <span class="product-label-link" type="condition" conceptid="4281749" conceptname="Heart valve disorder">cardiac valvulopathy</span> improved after discontinuation of pergolide.</span></p>
<p><span class="Bold">Fibrotic Complications</span></p>
<p><span class="Bold">Case reports have demonstrated that pergolide increases the risk of fibrotic complications including pulmonary, pleural, and/or <span class="product-label-link" type="condition" conceptid="4176725" conceptname="Retroperitoneal fibrosis">retroperitoneal fibrosis</span>, <span class="product-label-link" type="condition" conceptid="4138837" conceptname="Pericarditis">pericarditis</span>, <span class="product-label-link" type="condition" conceptid="78786" conceptname="Pleurisy">pleuritis</span>, and pericardial and/or <span class="product-label-link" type="condition" conceptid="254061" conceptname="Pleural effusion">pleural effusions</span>.  Cases have been reported after exposures to pergolide ranging from about one to several years.  Precise risk estimates of pergolide-induced fibrotic complications are not available. </span></p>
<p><span class="Bold">Specific risk factors predisposing patients to developing fibrotic complications with pergolide have not been identified.  Fibrotic complications have been reported with all therapeutic doses of pergolide.</span></p>
<p><span class="Bold">Pergolide is not recommended for use in patients with a history of fibrotic conditions.</span></p>
<p><span class="Bold">Patients should also be monitored for signs and symptoms of fibrotic complications, including <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span>, persistent <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough</span>, <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>, new cardiac rub, and/or signs of <span class="product-label-link" type="condition" conceptid="194406" conceptname="Urinary tract obstruction">urinary tract obstruction</span>. If a patient develops these signs or symptoms, consideration should be given to suspending treatment with pergolide until a full diagnostic evaluation has been performed. Pergolide should ordinarily be discontinued if a patient is diagnosed with a specific fibrotic complication. In some cases, signs and/or symptoms of fibrotic complications improved after discontinuation of pergolide.</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Permax<span class="Sup">®</span> (Pergolide Tablets, USP) is an ergot derivative dopamine receptor agonist at both D<span class="Sub">1</span> and D<span class="Sub">2</span> receptor sites. Pergolide mesylate is chemically designated as 8β-[(Methylthio)methyl]-6-propylergoline monomethanesulfonate; the structural formula is as follows:</p>
<div class="Figure"><img alt="Image from Drug Label Content" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=A26390E8-EB86-4623-8CDD-45B24B14DF74&amp;name=permax-figure-01.jpg"></div>
<p>The empirical formula is C<span class="Sub">19</span>H<span class="Sub">26</span>N<span class="Sub">2</span>S∙CH<span class="Sub">4</span>O<span class="Sub">3</span>S, representing a molecular weight of 410.60.</p>
<p>Permax is provided for oral administration in tablets containing 0.05 mg (0.159 µmol), 0.25 mg (0.795 µmol), or 1 mg (3.18 µmol) pergolide as the base. The tablets also contain croscarmellose sodium, iron oxide, lactose, magnesium stearate, and povidone. The 0.05 mg tablet also contains L-methionine, and the 0.25 mg tablet also contains FD&amp;C Blue No. 2.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<div class="Section">
<a name="section-3.1"></a><p></p>
<h2>Pharmacodynamic Information</h2>
<p class="First">Pergolide is a potent dopamine receptor agonist. Pergolide is 10 to 1000 times more potent than bromocriptine on a milligram per milligram basis in various in vitro and in vivo test systems. Pergolide inhibits the secretion of prolactin in humans; it causes a transient rise in serum concentrations of growth hormone and a decrease in serum concentrations of luteinizing hormone. In Parkinson's disease, pergolide is believed to exert its therapeutic effect by directly stimulating postsynaptic dopamine receptors in the nigrostriatal system.</p>
</div>
<div class="Section">
<a name="section-3.2"></a><p></p>
<h2>Pharmacokinetic Information (Absorption, Distribution, Metabolism, and Elimination)</h2>
<p class="First">Information on oral systemic bioavailability of pergolide is unavailable because of the lack of a sufficiently sensitive assay to detect the drug after the administration of a single dose. However, following oral administration of <span class="Sup">14</span>C radiolabeled pergolide, approximately 55% of the administered radioactivity can be recovered from the urine and 5% from expired CO<span class="Sub">2</span>, suggesting that a significant fraction is absorbed. Nothing can be concluded about the extent of presystemic clearance, if any.</p>
<p>Data on postabsorption distribution of pergolide are unavailable.</p>
<p>At least 10 metabolites have been detected, including N-despropylpergolide, pergolide sulfoxide, and pergolide sulfone. Pergolide sulfoxide and pergolide sulfone are dopamine agonists in animals. The other detected metabolites have not been identified and it is not known whether any other metabolites are active pharmacologically.</p>
<p>The major route of excretion is the kidney.</p>
<p>Pergolide is approximately 90% bound to plasma proteins. This extent of protein binding may be important to consider when pergolide is coadministered with other drugs known to affect protein binding.</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Permax is indicated as adjunctive treatment to levodopa/carbidopa in the management of the signs and symptoms of Parkinson's disease.</p>
<p>Evidence to support the efficacy of pergolide as an antiparkinsonian adjunct was obtained in a multicenter study enrolling 376 patients with mild to moderate Parkinson's disease who were intolerant to <span class="Italics">l</span>-dopa/carbidopa as manifested by moderate to severe <span class="product-label-link" type="condition" conceptid="4047115" conceptname="Oral dyskinesia">dyskinesia</span> and/or on-off phenomena. On average, the patients evaluated had been on <span class="Italics">l</span>-dopa/carbidopa for 3.9 years (range, 2 days to 16.8 years). The administration of pergolide permitted a 5% to 30% reduction in the daily dose of <span class="Italics">l</span>-dopa. On average, these patients treated with pergolide maintained an equivalent or better clinical status than they exhibited at baseline.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Pergolide is contraindicated in patients who are hypersensitive to this drug or other ergot derivatives.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="A8396953-1EDB-4930-9CD1-54ADF1856B41"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First"><span class="Bold Italics"><span class="product-label-link" type="condition" conceptid="4281749" conceptname="Heart valve disorder">Cardiac Valvulopathy</span> and Fibrotic Complications </span><span class="Bold">(SEE</span><a href="#A36516FE-5ABA-405E-A489-0CA83129C698">BOXED WARNING</a><span class="Bold">).</span></p>
<p><span class="Bold Italics"><span class="product-label-link" type="condition" conceptid="436583" conceptname="Fall">Falling</span> Asleep During Activities of Daily Living</span>—<span class="Bold">Patients treated with Permax have reported <span class="product-label-link" type="condition" conceptid="436583" conceptname="Fall">falling</span> asleep while engaged in activities of daily living, including the operation of motor vehicles which sometimes resulted in <span class="product-label-link" type="condition" conceptid="440279" conceptname="Accident">accidents</span>. Although many of these patients reported <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span> while on Permax, some perceived that they had no warning signs such as excessive <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, and believed that they were alert immediately prior to the event. Some of these events had been reported as late as 1 year after the initiation of treatment.</span></p>
<p><span class="Bold"><span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">Somnolence</span> is a common occurrence in patients receiving Permax. Many clinical experts believe that <span class="product-label-link" type="condition" conceptid="436583" conceptname="Fall">falling</span> asleep while engaged in activities of daily living always occurs in a setting of preexisting <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span>, although patients may not give such a history. For this reason, prescribers should continually reassess patients for <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> or <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">sleepiness</span>, especially since some of the events occur well after the start of treatment. Prescribers should also be aware that patients may not acknowledge <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> or <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">sleepiness</span> until directly questioned about <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> or <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">sleepiness</span> during specific activities.</span></p>
<p><span class="Bold">Before initiating treatment with Permax, patients should be advised of the potential to develop <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> and specifically asked about factors that may increase the risk with Permax such as concomitant sedating medications or the presence of <span class="product-label-link" type="condition" conceptid="435524" conceptname="Sleep disorder">sleep disorders</span>. If a patient develops significant <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">daytime sleepiness</span> or episodes of <span class="product-label-link" type="condition" conceptid="436583" conceptname="Fall">falling</span> asleep during activities that require participation (e.g., conversations, eating, etc.), Permax should ordinarily be discontinued. If a decision is made to continue Permax, patients should be advised to not drive and to avoid other potentially dangerous activities.</span></p>
<p><span class="Bold">While dose reduction may reduce the degree of <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span>, there is insufficient information to establish that dose reduction will eliminate episodes of <span class="product-label-link" type="condition" conceptid="436583" conceptname="Fall">falling</span> asleep while engaged in activities of daily living.</span></p>
<p><span class="Italics">Symptomatic <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">Hypotension</span> </span>— In clinical trials, approximately 10% of patients taking pergolide with <span class="Italics">l</span>-dopa versus 7% taking placebo with <span class="Italics">l</span>-dopa experienced symptomatic orthostatic and/or sustained <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, especially during initial treatment. With gradual dosage titration, tolerance to the <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> usually develops. It is therefore important to warn patients of the risk, to begin therapy with low doses, and to increase the dosage in carefully adjusted increments over a period of 3 to 4 weeks (<span class="Italics">see</span><a href="#A7F1360A-3D0D-49A0-93E8-FD0BEDE6837B">DOSAGE AND ADMINISTRATION</a>).</p>
<p><span class="Italics">Hallucinosis</span>— In controlled trials, pergolide with <span class="Italics">l</span>-dopa caused hallucinosis in about 14% of patients as opposed to 3% taking placebo with <span class="Italics">l</span>-dopa. This was of sufficient severity to cause discontinuation of treatment in about 3% of those enrolled; tolerance to this untoward effect was not observed.</p>
<p><span class="Italics">Fatalities</span>— In the placebo-controlled trial, 2 of 187 patients treated with placebo died as compared with 1 of 189 patients treated with pergolide. Of the 2299 patients treated with pergolide in premarketing studies evaluated as of October 1988, 143 died while on the drug or shortly after discontinuing it. Because the patient population under evaluation was elderly, ill, and at high risk for <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>, it seems unlikely that pergolide played any role in these <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">deaths</span>, but the possibility that pergolide shortens survival of patients cannot be excluded with absolute certainty.</p>
<p>In particular, a case-by-case review of the clinical course of the patients who died failed to disclose any unique set of signs, symptoms, or laboratory results that would suggest that treatment with pergolide caused their <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">deaths</span>. Sixty-eight percent (68%) of the patients who died were 65 years of age or older. No <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> (other than a <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">suicide</span>) occurred within the first month of treatment; most of the patients who died had been on pergolide for years. A relative frequency of the causes of <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> by organ system are: Pulmonary failure/<span class="product-label-link" type="condition" conceptid="255848" conceptname="Pneumonia">Pneumonia</span>, 35%; Cardiovascular, 30%; Cancer, 11%; Unknown, 8.4%; <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">Infection</span>, 3.5%; <span class="product-label-link" type="condition" conceptid="373747" conceptname="Extrapyramidal disease">Extrapyramidal syndrome</span>, 3.5%; <span class="product-label-link" type="condition" conceptid="381316" conceptname="Cerebrovascular accident">Stroke</span>, 2.1%; <span class="product-label-link" type="condition" conceptid="31317" conceptname="Dysphagia">Dysphagia</span>, 2.1%; Injury, 1.4%; <span class="product-label-link" type="condition" conceptid="440925" conceptname="Suicide">Suicide</span>, 1.4%; <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">Dehydration</span>, 0.7%; <span class="product-label-link" type="condition" conceptid="4263367" conceptname="Glomerulonephritis">Glomerulonephritis</span>, 0.7%.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="section-7.1"></a><p></p>
<h2>General</h2>
<p class="First">Caution should be exercised when administering pergolide to patients prone to <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">cardiac dysrhythmias</span>.</p>
<p>In a study comparing pergolide and placebo, patients taking pergolide were found to have significantly more episodes of atrial premature contractions (APCs) and <span class="product-label-link" type="condition" conceptid="4007310" conceptname="Sinus tachycardia">sinus tachycardia</span>.</p>
<p>The use of pergolide in patients on <span class="Italics">l</span>-dopa may cause and/or exacerbate preexisting states of <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span> and <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span> (<span class="Italics">see</span><a href="#A8396953-1EDB-4930-9CD1-54ADF1856B41">WARNINGS</a>) and preexisting <span class="product-label-link" type="condition" conceptid="4047115" conceptname="Oral dyskinesia">dyskinesia</span>. Also, the abrupt discontinuation of pergolide in patients receiving it chronically as an adjunct to <span class="Italics">l</span>-dopa may precipitate the onset of <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span> and <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>; these may occur within a span of several days. Discontinuation of pergolide should be undertaken gradually whenever possible, even if the patient is to remain on <span class="Italics">l</span>-dopa.</p>
<p>A symptom complex resembling the <span class="product-label-link" type="condition" conceptid="379802" conceptname="Neuroleptic malignant syndrome">neuroleptic malignant syndrome</span> (NMS) (characterized by elevated temperature, muscular <span class="product-label-link" type="condition" conceptid="4050941" conceptname="Muscle rigidity">rigidity</span>, altered consciousness, and <span class="product-label-link" type="condition" conceptid="434633" conceptname="Disorder of autonomic nervous system">autonomic instability</span>), with no other obvious etiology, has been reported in association with rapid dose reduction, withdrawal of, or changes in antiparkinsonian therapy, including pergolide.</p>
<p><span class="Bold">Raynaud’s Phenomenon</span></p>
<p>Pergolide can rarely cause Raynaud’s phenomenon.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-7.2"></a><p></p>
<h2>Information for Patients</h2>
<p class="First">Because pergolide may cause <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span> and the possibility of <span class="product-label-link" type="condition" conceptid="436583" conceptname="Fall">falling</span> asleep during activities of daily living, patients should be cautioned about operating hazardous machinery, including automobiles, until they are reasonably certain that pergolide therapy does not affect them adversely. Patients should be advised that if increased <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span> or new episodes of <span class="product-label-link" type="condition" conceptid="436583" conceptname="Fall">falling</span> asleep during activities of daily living (e.g., watching television, passenger in a car, etc.) are experienced at any time during treatment, they should not drive or participate in potentially dangerous activities until they have contacted their physician. Due to the possible additive sedative effects, caution should also be used when patients are taking other CNS depressants in combination with pergolide.</p>
<p>Patients and their families should be informed of the common adverse consequences of the use of pergolide (<span class="Italics">see</span><a href="#A526DD16-1946-4EF6-9F84-5EB6E2705935">ADVERSE REACTIONS</a>) and the risk of <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> (<span class="Italics">see</span><a href="#A8396953-1EDB-4930-9CD1-54ADF1856B41">WARNINGS</a>).</p>
<p>Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during therapy.</p>
<p>Patients should be advised to notify their physician if they are breast feeding an infant.</p>
<p>As with other dopamine agonists, compulsive self-rewarding behavior (e.g., pathologic <span class="product-label-link" type="condition" conceptid="4023166" conceptname="Gambling">gambling</span>) and libido increase have been reported in patients receiving pergolide therapy.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="section-7.3"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">No specific laboratory tests are deemed essential for the management of patients on Permax. Periodic routine evaluation of all patients, however, is appropriate.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-7.4"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); these agents may diminish the effectiveness of Permax.</p>
<p>Because pergolide is approximately 90% bound to plasma proteins, caution should be exercised if pergolide is coadministered with other drugs known to affect protein binding.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-7.5"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">A 2-year carcinogenicity study was conducted in mice using dietary levels of pergolide equivalent to oral doses of 0.6, 3.7, and 36.4 mg/kg/day in males and 0.6, 4.4, and 40.8 mg/kg/day in females. A 2-year study in rats was conducted using dietary levels equivalent to oral doses of 0.04, 0.18, and 0.88 mg/kg/day in males and 0.05, 0.28, and 1.42 mg/kg/day in females. The highest doses tested in the mice and rats were approximately 340 and 12 times the maximum human oral dose administered in controlled clinical trials (6 mg/day equivalent to 0.12 mg/kg/day).</p>
<p>A low incidence of uterine neoplasms occurred in both rats and mice. Endometrial <span class="product-label-link" type="condition" conceptid="4106411" conceptname="Adenofibroma">adenomas</span> and carcinomas were observed in rats. Endometrial <span class="product-label-link" type="condition" conceptid="4084784" conceptname="Sarcoma">sarcomas</span> were observed in mice. The occurrence of these neoplasms is probably attributable to the high estrogen/progesterone ratio that would occur in rodents as a result of the prolactin-inhibiting action of pergolide. The endocrine mechanisms believed to be involved in the rodents are not present in humans. However, even though there is no known correlation between uterine malignancies occurring in pergolide-treated rodents and human risk, there are no human data to substantiate this conclusion.</p>
<p>Pergolide was evaluated for mutagenic potential in a battery of tests that included an Ames bacterial mutation assay, a DNA repair assay in cultured rat hepatocytes, an in vitro mammalian cell gene mutation assay in cultured L5178Y cells, and a determination of chromosome alteration in bone marrow cells of Chinese hamsters. A weak mutagenic response was noted in the mammalian cell gene mutation assay only after metabolic activation with rat liver microsomes. No mutagenic effects were obtained in the 2 other in vitro assays and in the in vivo assay. The relevance of these findings in humans is unknown.</p>
<p>A fertility study in male and female mice showed that fertility was maintained at 0.6 and 1.7 mg/kg/day but decreased at 5.6 mg/kg/day. Prolactin has been reported to be involved in stimulating and maintaining progesterone levels required for implantation in mice and, therefore, the impaired fertility at the high dose may have occurred because of depressed prolactin levels.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-7.6"></a><p></p>
<h2>Usage in Pregnancy − Pregnancy Category B</h2>
<p class="First">Reproduction studies were conducted in mice at doses of 5, 16, and 45 mg/kg/day and in rabbits at doses of 2, 6, and 16 mg/kg/day. The highest doses tested in mice and rabbits were 375 and 133 times the 6 mg/day maximum human dose administered in controlled clinical trials. In these studies, there was no evidence of harm to the fetus due to pergolide.</p>
<p>There are, however, no adequate and well-controlled studies in pregnant women. Among women who received pergolide for <span class="product-label-link" type="condition" conceptid="31821" conceptname="Disorder of endocrine system">endocrine disorders</span> in premarketing studies, there were 33 pregnancies that resulted in healthy babies and 6 pregnancies that resulted in congenital abnormalities (3 major, 3 minor); a causal relationship has not been established. Because human data are limited and because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-7.7"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether this drug is excreted in human milk. The pharmacologic action of pergolide suggests that it may interfere with lactation. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions to pergolide in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-7.8"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness in pediatric patients have not been established.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="section-7.9"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">Of the total number of subjects in clinical studies of pergolide, 78 were 65 and over. There were no apparent differences in efficacy between these subjects and younger subjects. There was an increased incidence of <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span>, and <span class="product-label-link" type="condition" conceptid="4094513" conceptname="Ankle edema">peripheral edema</span> in patients 65 and over. Other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="A526DD16-1946-4EF6-9F84-5EB6E2705935"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First"><span class="Italics">Commonly Observed</span>— In premarketing clinical trials, the most commonly observed adverse events associated with use of pergolide which were not seen at an equivalent incidence among placebo-treated patients were: nervous system complaints, including <span class="product-label-link" type="condition" conceptid="4047115" conceptname="Oral dyskinesia">dyskinesia</span>, <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>; digestive complaints, including <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">dyspepsia</span>; and respiratory system complaints, including <span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">rhinitis</span>.</p>
<p><span class="Italics">Associated With Discontinuation of Treatment</span>— Twenty-seven percent (27%) of approximately 1200 patients receiving pergolide for treatment of Parkinson's disease in premarketing clinical trials in the US and Canada discontinued treatment due to adverse events. The events most commonly causing discontinuation were related to the nervous system (15.5%), primarily <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span> (7.8%) and <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span> (1.8%).</p>
<p><span class="Italics">Fatalities —</span><span class="Italics">see</span><a href="#A8396953-1EDB-4930-9CD1-54ADF1856B41">WARNINGS</a></p>
<p><span class="Italics">Incidence in Controlled Clinical Trials</span>— The table that follows enumerates adverse events that occurred at a frequency of 1% or more among patients taking pergolide who participated in the premarketing controlled clinical trials comparing pergolide with placebo. In a double-blind, controlled study of 6 months’ duration, patients with Parkinson’s disease were continued on <span class="Italics">l</span>-dopa/carbidopa and were randomly assigned to receive either pergolide or placebo as additional therapy.</p>
<p>The prescriber should be aware that these figures cannot be used to predict the incidence of side effects in the course of usual medical practice where patient characteristics and other factors differ from those which prevailed in the clinical trials. Similarly, the cited frequencies cannot be compared with figures obtained from other clinical investigations involving different treatments, uses, and investigators. The cited figures, however, do provide the prescribing physician with some basis for estimating the relative contribution of drug and nondrug factors to the side-effect incidence rate in the population studied.</p>
<table frame="void">
<caption><span>Incidence of Treatment-Emergent Adverse Experiences in the Placebo-Controlled Clinical Trial</span></caption>
<thead>
<tr class="First">
<th valign="top"></th>
<th align="right" colspan="2" valign="top"><span class="Bold">Percentage of Patients Reporting Events</span></th>
</tr>
<tr>
<td valign="top"></td>
<td align="center" valign="top"><span class="Bold">Pergolide</span></td>
<td align="center" valign="top"><span class="Bold">Placebo</span></td>
</tr>
<tr class="Last">
<td align="left" valign="top"><span class="Bold">Body system/Adverse Event*</span></td>
<td align="center" valign="top"><span class="Bold">N=189</span></td>
<td align="center" valign="top"><span class="Bold">N=187</span></td>
</tr>
</thead>
<tfoot><tr class="First Last"><td colspan="3" valign="top">*Events reported by at least 1% of patients receiving pergolide are included.</td></tr></tfoot>
<tbody>
<tr class="First">
<td valign="top"><span class="Bold">Body as a Whole</span></td>
<td align="center" valign="top"></td>
<td align="center" valign="top"></td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">Pain</span></td>
<td align="center" valign="top">7.0</td>
<td align="center" valign="top">2.1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">Abdominal pain</span></td>
<td align="center" valign="top">5.8</td>
<td align="center" valign="top">2.1</td>
</tr>
<tr>
<td valign="top">Injury, <span class="product-label-link" type="condition" conceptid="440279" conceptname="Accident">accident</span></td>
<td align="center" valign="top">5.8</td>
<td align="center" valign="top">7.0</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span></td>
<td align="center" valign="top">5.3</td>
<td align="center" valign="top">6.4</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">Asthenia</span></td>
<td align="center" valign="top">4.2</td>
<td align="center" valign="top">4.8</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">Chest pain</span></td>
<td align="center" valign="top">3.7</td>
<td align="center" valign="top">2.1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">Flu syndrome</span></td>
<td align="center" valign="top">3.2</td>
<td align="center" valign="top">2.1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="24134" conceptname="Neck pain">Neck pain</span></td>
<td align="center" valign="top">2.7</td>
<td align="center" valign="top">1.6</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="134736" conceptname="Backache">Back pain</span></td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">2.1</td>
</tr>
<tr>
<td valign="top">Surgical procedure</td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">Chills</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td valign="top">Face <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">Infection</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td valign="top"><span class="Bold">Cardiovascular</span></td>
<td align="center" valign="top"></td>
<td align="center" valign="top"></td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="319041" conceptname="Orthostatic hypotension">Postural hypotension</span></td>
<td align="center" valign="top">9.0</td>
<td align="center" valign="top">7.0</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4237053" conceptname="Vasodilatation">Vasodilatation</span></td>
<td align="center" valign="top">3.2</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">Palpitation</span></td>
<td align="center" valign="top">2.1</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">Hypotension</span></td>
<td align="center" valign="top">2.1</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">Syncope</span></td>
<td align="center" valign="top">2.1</td>
<td align="center" valign="top">1.1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">Hypertension</span></td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">1.1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">Arrhythmia</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4329847" conceptname="Myocardial infarction">Myocardial infarction</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top"><span class="Bold">Digestive</span></td>
<td align="center" valign="top"></td>
<td align="center" valign="top"></td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span></td>
<td align="center" valign="top">24.3</td>
<td align="center" valign="top">12.8</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">Constipation</span></td>
<td align="center" valign="top">10.6</td>
<td align="center" valign="top">5.9</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span></td>
<td align="center" valign="top">6.4</td>
<td align="center" valign="top">2.7</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">Dyspepsia</span></td>
<td align="center" valign="top">6.4</td>
<td align="center" valign="top">2.1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">Anorexia</span></td>
<td align="center" valign="top">4.8</td>
<td align="center" valign="top">2.7</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">Dry mouth</span></td>
<td align="center" valign="top">3.7</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top">Vomitting</td>
<td align="center" valign="top">2.7</td>
<td align="center" valign="top">1.6</td>
</tr>
<tr>
<td valign="top"><span class="Bold">Hemic and Lymphatic</span></td>
<td align="center" valign="top"></td>
<td align="center" valign="top"></td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="439777" conceptname="Anemia">Anemia</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top"><span class="Bold">Metabolic and Nutritional</span></td>
<td align="center" valign="top"></td>
<td align="center" valign="top"></td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4094513" conceptname="Ankle edema">Peripheral edema</span></td>
<td align="center" valign="top">7.4</td>
<td align="center" valign="top">4.3</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">Edema</span></td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4134784" conceptname="Weight increased">Weight gain</span></td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td valign="top"><span class="Bold">Musuloskeletal</span></td>
<td align="center" valign="top"></td>
<td align="center" valign="top"></td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">Arthralgia</span></td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">2.1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="134453" conceptname="Bursitis">Bursitis</span></td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">Myalgia</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4247265" conceptname="Muscle twitch">Twitching</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td valign="top"><span class="Bold">Nervous System</span></td>
<td align="center" valign="top"></td>
<td align="center" valign="top"></td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4047115" conceptname="Oral dyskinesia">Dyskinesia</span></td>
<td align="center" valign="top">62.4</td>
<td align="center" valign="top">24.6</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">Dizziness</span></td>
<td align="center" valign="top">19.1</td>
<td align="center" valign="top">13.9</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">Hallucinations</span></td>
<td align="center" valign="top">13.8</td>
<td align="center" valign="top">3.2</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="375800" conceptname="Dystonia">Dystonia</span></td>
<td align="center" valign="top">11.6</td>
<td align="center" valign="top">8.0</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">Confusion</span></td>
<td align="center" valign="top">11.1</td>
<td align="center" valign="top">9.6</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">Somnolence</span></td>
<td align="center" valign="top">10.1</td>
<td align="center" valign="top">3.7</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">Insomnia</span></td>
<td align="center" valign="top">7.9</td>
<td align="center" valign="top">3.2</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">Anxiety</span></td>
<td align="center" valign="top">6.4</td>
<td align="center" valign="top">4.3</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">Tremor</span></td>
<td align="center" valign="top">4.2</td>
<td align="center" valign="top">7.5</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">Depression</span></td>
<td align="center" valign="top">3.2</td>
<td align="center" valign="top">5.4</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4304251" conceptname="Bizarre dreams">Abnormal dreams</span></td>
<td align="center" valign="top">2.7</td>
<td align="center" valign="top">4.3</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="441838" conceptname="Personality disorder">Personality disorder</span></td>
<td align="center" valign="top">2.1</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">Psychosis</span></td>
<td align="center" valign="top">2.1</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="437643" conceptname="Abnormal gait">Abnormal gait</span></td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">1.6</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4108925" conceptname="Akathisia">Akathisia</span></td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="373747" conceptname="Extrapyramidal disease">Extrapyramidal syndrome</span></td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">1.1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="441417" conceptname="Incoordination">Incoordination</span></td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">Paresthesia</span></td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">3.2</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4143471" conceptname="Akinesia">Akinesia</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">1.1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4208994" conceptname="Increased muscle tone">Hypertonia</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="373852" conceptname="Neuralgia">Neuralgia</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top">Speech disorder</td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">1.6</td>
</tr>
<tr>
<td valign="top"><span class="Bold">Respiratory system</span></td>
<td align="center" valign="top"></td>
<td align="center" valign="top"></td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">Rhinitis</span></td>
<td align="center" valign="top">12.2</td>
<td align="center" valign="top">5.4</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">Dyspnea</span></td>
<td align="center" valign="top">4.8</td>
<td align="center" valign="top">1.1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="318556" conceptname="Epistaxis">Epistaxis</span></td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">&lt;1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="194475" conceptname="Hiccoughs">Hiccup</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td valign="top"><span class="Bold">Skin and Appendages</span></td>
<td align="center" valign="top"></td>
<td align="center" valign="top"></td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">Rash</span></td>
<td align="center" valign="top">3.2</td>
<td align="center" valign="top">2.1</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">Sweating</span></td>
<td align="center" valign="top">2.1</td>
<td align="center" valign="top">2.7</td>
</tr>
<tr>
<td valign="top"><span class="Bold">Special Senses</span></td>
<td align="center" valign="top"></td>
<td align="center" valign="top"></td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="373786" conceptname="Abnormal vision">Abnormal vision</span></td>
<td align="center" valign="top">5.8</td>
<td align="center" valign="top">5.4</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="373474" conceptname="Diplopia">Diplopia</span></td>
<td align="center" valign="top">2.1</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="436235" conceptname="Taste sense altered">Taste perversion</span></td>
<td align="center" valign="top">1.6</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="375252" conceptname="Disorder of eye">Eye disorder</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">0</td>
</tr>
<tr>
<td valign="top"><span class="Bold">Urogenital System</span></td>
<td align="center" valign="top"></td>
<td align="center" valign="top"></td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="4012368" conceptname="Increased frequency of urination">Urinary frequency</span></td>
<td align="center" valign="top">2.7</td>
<td align="center" valign="top">6.4</td>
</tr>
<tr>
<td valign="top"><span class="product-label-link" type="condition" conceptid="81902" conceptname="Urinary tract infectious disease">Urinary tract infection</span></td>
<td align="center" valign="top">2.7</td>
<td align="center" valign="top">3.7</td>
</tr>
<tr class="Last">
<td valign="top"><span class="product-label-link" type="condition" conceptid="75004" conceptname="Frank hematuria">Hematuria</span></td>
<td align="center" valign="top">1.1</td>
<td align="center" valign="top">&lt;1</td>
</tr>
</tbody>
</table>
<p><span class="Italics">Events Observed During the Premarketing Evaluation of Permax</span>— This section reports event frequencies evaluated as of October 1988 for adverse events occurring in a group of approximately 1800 patients who took multiple doses of pergolide. The conditions and duration of exposure to pergolide varied greatly, involving well-controlled studies as well as experience in open and uncontrolled clinical settings. In the absence of appropriate controls in some of the studies, a causal relationship between these events and treatment with pergolide cannot be determined.</p>
<p>The following enumeration by organ system describes events in terms of their relative frequency of reporting in the data base. Events of major clinical importance are also described in the Warnings and Precautions sections.</p>
<p>The following definitions of frequency are used: frequent adverse events are defined as those occurring in at least 1/100 patients; infrequent adverse events are those occurring in 1/100 to 1/1000 patients; rare events are those occurring in fewer than 1/1000 patients.</p>
<p><span class="Bold">Body as a Whole</span>—<span class="Italics">Frequent:</span> <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">asthenia</span>, <span class="product-label-link" type="condition" conceptid="433633" conceptname="Late effect of superficial injury">accidental injury</span>, <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>, <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>, <span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">chest pain</span>, <span class="product-label-link" type="condition" conceptid="134736" conceptname="Backache">back pain</span>, <span class="product-label-link" type="condition" conceptid="4266367" conceptname="Influenza">flu syndrome</span>, <span class="product-label-link" type="condition" conceptid="24134" conceptname="Neck pain">neck pain</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span>; <span class="Italics">Infrequent:</span> facial <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>, <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">chills</span>, enlarged abdomen, <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">malaise</span>, neoplasm, <span class="product-label-link" type="condition" conceptid="199860" conceptname="Hernia of abdominal cavity">hernia</span>, <span class="product-label-link" type="condition" conceptid="4147829" conceptname="Pain in pelvis">pelvic pain</span>, <span class="product-label-link" type="condition" conceptid="132797" conceptname="Sepsis">sepsis</span>, <span class="product-label-link" type="condition" conceptid="435613" conceptname="Cellulitis">cellulitis</span>, <span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">moniliasis</span>, <span class="product-label-link" type="condition" conceptid="444202" conceptname="Abscess">abscess</span>, <span class="product-label-link" type="condition" conceptid="4168686" conceptname="Jaw pain">jaw pain</span>, <span class="product-label-link" type="condition" conceptid="435371" conceptname="Hypothermia">hypothermia</span>; <span class="Italics">Rare:</span> acute abdominal syndrome, <span class="product-label-link" type="condition" conceptid="257628" conceptname="Systemic lupus erythematosus">LE syndrome</span>.</p>
<p><span class="Bold">Cardiovascular System</span>—<span class="Italics">Frequent:</span> <span class="product-label-link" type="condition" conceptid="319041" conceptname="Orthostatic hypotension">postural hypotension</span>, <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">syncope</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitations</span>, <span class="product-label-link" type="condition" conceptid="4237053" conceptname="Vasodilatation">vasodilatations</span>, <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">congestive heart failure</span>; <span class="Italics">Infrequent:</span> <span class="product-label-link" type="condition" conceptid="4329847" conceptname="Myocardial infarction">myocardial infarction</span>, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">heart arrest</span>, abnormal electrocardiogram, <span class="product-label-link" type="condition" conceptid="321318" conceptname="Angina pectoris">angina pectoris</span>, <span class="product-label-link" type="condition" conceptid="320741" conceptname="Thrombophlebitis">thrombophlebitis</span>, <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span>, <span class="product-label-link" type="condition" conceptid="4008580" conceptname="Ventricular bigeminy">ventricular extrasystoles</span>, <span class="product-label-link" type="condition" conceptid="381316" conceptname="Cerebrovascular accident">cerebrovascular accident</span>, <span class="product-label-link" type="condition" conceptid="4103295" conceptname="Ventricular tachycardia">ventricular tachycardia</span>, <span class="product-label-link" type="condition" conceptid="374384" conceptname="Cerebral ischemia">cerebral ischemia</span>, <span class="product-label-link" type="condition" conceptid="313217" conceptname="Atrial fibrillation">atrial fibrillation</span>, <span class="product-label-link" type="condition" conceptid="441644" conceptname="Varicose veins of legs in pregnancy and the puerperium">varicose vein</span>, <span class="product-label-link" type="condition" conceptid="440417" conceptname="Pulmonary embolism">pulmonary embolus</span>, <span class="product-label-link" type="condition" conceptid="316135" conceptname="Atrioventricular block">AV block</span>, <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span>; <span class="Italics">Rare:</span> <span class="product-label-link" type="condition" conceptid="4137275" conceptname="Vasculitis">vasculitis</span>, <span class="product-label-link" type="condition" conceptid="4322024" conceptname="Pulmonary hypertension">pulmonary hypertension</span>, <span class="product-label-link" type="condition" conceptid="4138837" conceptname="Pericarditis">pericarditis</span>, <span class="product-label-link" type="condition" conceptid="318736" conceptname="Migraine">migraine</span>, <span class="product-label-link" type="condition" conceptid="316135" conceptname="Atrioventricular block">heart block</span>, <span class="product-label-link" type="condition" conceptid="376713" conceptname="Cerebral hemorrhage">cerebral hemorrhage</span>.</p>
<p><span class="Bold">Digestive System</span>—<span class="Italics">Frequent:</span> <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="23325" conceptname="Heartburn">dyspepsia</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>, <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span>, <span class="product-label-link" type="condition" conceptid="31317" conceptname="Dysphagia">dysphagia</span>; <span class="Italics">Infrequent:</span> <span class="product-label-link" type="condition" conceptid="4012503" conceptname="Excessive upper gastrointestinal gas">flatulence</span>, <span class="product-label-link" type="condition" conceptid="438878" conceptname="Liver function tests abnormal">abnormal liver function tests</span>, <span class="product-label-link" type="condition" conceptid="4217027" conceptname="Increased appetite">increased appetite</span>, <span class="product-label-link" type="condition" conceptid="28461" conceptname="Hypertrophy of salivary gland">salivary gland enlargement</span>, <span class="product-label-link" type="condition" conceptid="4241197" conceptname="Thirst">thirst</span>, <span class="product-label-link" type="condition" conceptid="4101468" conceptname="Gastroenteritis">gastroenteritis</span>, <span class="product-label-link" type="condition" conceptid="201340" conceptname="Gastritis">gastritis</span>, <span class="product-label-link" type="condition" conceptid="4103655" conceptname="Dental abscess">periodontal abscess</span>, <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">intestinal obstruction</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="4281516" conceptname="Gingivitis">gingivitis</span>, <span class="product-label-link" type="condition" conceptid="30753" conceptname="Esophagitis">esophagitis</span>, <span class="product-label-link" type="condition" conceptid="4098112" conceptname="Biliary sludge">cholelithiasis</span>, <span class="product-label-link" type="condition" conceptid="133228" conceptname="Dental caries">tooth caries</span>, <span class="product-label-link" type="condition" conceptid="194990" conceptname="Inflammatory disease of liver">hepatitis</span>, <span class="product-label-link" type="condition" conceptid="4265600" conceptname="Gastric ulcer">stomach ulcer</span>, <span class="product-label-link" type="condition" conceptid="193809" conceptname="Melena due to gastrointestinal hemorrhage">melena</span>, <span class="product-label-link" type="condition" conceptid="197676" conceptname="Large liver">hepatomegaly</span>, <span class="product-label-link" type="condition" conceptid="26727" conceptname="Hematemesis">hematemesis</span>, <span class="product-label-link" type="condition" conceptid="4152350" conceptname="Burping">eructation</span>; <span class="Italics">Rare:</span> <span class="product-label-link" type="condition" conceptid="29056" conceptname="Sialoadenitis">sialadenitis</span>, <span class="product-label-link" type="condition" conceptid="4027663" conceptname="Peptic ulcer">peptic ulcer</span>, <span class="product-label-link" type="condition" conceptid="4192640" conceptname="Pancreatitis">pancreatitis</span>, <span class="product-label-link" type="condition" conceptid="137977" conceptname="Jaundice">jaundice</span>, <span class="product-label-link" type="condition" conceptid="436147" conceptname="Glossitis">glossitis</span>, <span class="product-label-link" type="condition" conceptid="197675" conceptname="Incontinence of feces">fecal incontinence</span>, <span class="product-label-link" type="condition" conceptid="433516" conceptname="Duodenitis">duodenitis</span>, <span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span>, <span class="product-label-link" type="condition" conceptid="192956" conceptname="Cholecystitis">cholecystitis</span>, <span class="product-label-link" type="condition" conceptid="138463" conceptname="Aphthous ulcer of mouth">aphthous stomatitis</span>, <span class="product-label-link" type="condition" conceptid="25844" conceptname="Ulcer of esophagus">esophageal ulcer</span>.</p>
<p><span class="Bold">Endocrine System</span>—<span class="Italics">Infrequent:</span> <span class="product-label-link" type="condition" conceptid="140673" conceptname="Hypothyroidism">hypothyroidism</span>, <span class="product-label-link" type="condition" conceptid="4106411" conceptname="Adenofibroma">adenoma</span>, <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span> mellitus, <span class="product-label-link" type="condition" conceptid="4207539" conceptname="Syndrome of inappropriate vasopressin secretion">ADH inappropriate</span>; <span class="Italics">Rare:</span> <span class="product-label-link" type="condition" conceptid="31821" conceptname="Disorder of endocrine system">endocrine disorder</span>, <span class="product-label-link" type="condition" conceptid="4114219" conceptname="Thyroid adenoma">thyroid adenoma</span>.</p>
<p><span class="Bold">Hemic and Lymphatic System</span>—<span class="Italics">Frequent:</span> <span class="product-label-link" type="condition" conceptid="439777" conceptname="Anemia">anemia</span>; <span class="Italics">Infrequent:</span> <span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">leukopenia</span>, <span class="product-label-link" type="condition" conceptid="315085" conceptname="Lymphadenopathy">lymphadenopathy</span>, <span class="product-label-link" type="condition" conceptid="438398" conceptname="Leukocytosis">leukocytosis</span>, <span class="product-label-link" type="condition" conceptid="432870" conceptname="Thrombocytopenic disorder">thrombocytopenia</span>, <span class="product-label-link" type="condition" conceptid="4155911" conceptname="Petechiae">petechia</span>, <span class="product-label-link" type="condition" conceptid="435789" conceptname="Megaloblastic anemia">megaloblastic anemia</span>, <span class="product-label-link" type="condition" conceptid="438555" conceptname="Cyanosis">cyanosis</span>; <span class="Italics">Rare:</span> <span class="product-label-link" type="condition" conceptid="4047773" conceptname="Purpura">purpura</span>, <span class="product-label-link" type="condition" conceptid="320074" conceptname="Lymphocytosis">lymphocytosis</span>, <span class="product-label-link" type="condition" conceptid="4302954" conceptname="Disorder characterized by eosinophilia">eosinophilia</span>, <span class="product-label-link" type="condition" conceptid="4280071" conceptname="Thrombocytosis">thrombocythemia</span>, <span class="product-label-link" type="condition" conceptid="134305" conceptname="Acute lymphoid leukemia">acute lymphoblastic leukemia</span>, <span class="product-label-link" type="condition" conceptid="435790" conceptname="Secondary polycythemia">polycythemia</span>, <span class="product-label-link" type="condition" conceptid="200527" conceptname="Splenomegaly">splenomegaly</span>.</p>
<p><span class="Bold">Metabolic and Nutritional System</span>—<span class="Italics">Frequent:</span> <span class="product-label-link" type="condition" conceptid="4094513" conceptname="Ankle edema">peripheral edema</span>, <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span>, <span class="product-label-link" type="condition" conceptid="4134784" conceptname="Weight increased">weight gain</span>; <span class="Italics">Infrequent:</span> <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span>, <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span>, <span class="product-label-link" type="condition" conceptid="24609" conceptname="Hypoglycemia">hypoglycemia</span>, <span class="product-label-link" type="condition" conceptid="433168" conceptname="Iron deficiency anemia secondary to inadequate dietary iron intake">iron deficiency anemia</span>, <span class="product-label-link" type="condition" conceptid="4214376" conceptname="Hyperglycemia">hyperglycemia</span>, <span class="product-label-link" type="condition" conceptid="440674" conceptname="Gout">gout</span>, <span class="product-label-link" type="condition" conceptid="437827" conceptname="Pure hypercholesterolemia">hypercholesteremia</span>; <span class="Italics">Rare:</span> <span class="product-label-link" type="condition" conceptid="4022093" conceptname="Electrolyte imbalance">electrolyte imbalance</span>, <span class="product-label-link" type="condition" conceptid="134765" conceptname="Cachexia">cachexia</span>, <span class="product-label-link" type="condition" conceptid="435517" conceptname="Acidosis">acidosis</span>, <span class="product-label-link" type="condition" conceptid="4147761" conceptname="Hyperuricemia">hyperuricemia</span>.</p>
<p><span class="Bold">Musculoskeletal System</span>—<span class="Italics">Frequent:</span> <span class="product-label-link" type="condition" conceptid="4247265" conceptname="Muscle twitch">twitching</span>, <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">myalgia</span>, <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">arthralgia</span>; <span class="Italics">Infrequent:</span> <span class="product-label-link" type="condition" conceptid="4129418" conceptname="Bone pain">bone pain</span>, <span class="product-label-link" type="condition" conceptid="4195698" conceptname="Tenosynovitis">tenosynovitis</span>, <span class="product-label-link" type="condition" conceptid="73001" conceptname="Myositis">myositis</span>, bone <span class="product-label-link" type="condition" conceptid="4084784" conceptname="Sarcoma">sarcoma</span>, <span class="product-label-link" type="condition" conceptid="4291025" conceptname="Arthritis">arthritis</span>; <span class="Italics">Rare:</span> <span class="product-label-link" type="condition" conceptid="80502" conceptname="Osteoporosis">osteoporosis</span>, <span class="product-label-link" type="condition" conceptid="78236" conceptname="Muscle atrophy">muscle atrophy</span>, <span class="product-label-link" type="condition" conceptid="141663" conceptname="Osteomyelitis">osteomyelitis</span>.</p>
<p><span class="Bold">Nervous System</span>—<span class="Italics">Frequent:</span> <span class="product-label-link" type="condition" conceptid="4047115" conceptname="Oral dyskinesia">dyskinesia</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="375800" conceptname="Dystonia">dystonia</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesia</span>, <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">anxiety</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="4143471" conceptname="Akinesia">akinesia</span>, <span class="product-label-link" type="condition" conceptid="373747" conceptname="Extrapyramidal disease">extrapyramidal syndrome</span>, <span class="product-label-link" type="condition" conceptid="437643" conceptname="Abnormal gait">abnormal gait</span>, <span class="product-label-link" type="condition" conceptid="4304251" conceptname="Bizarre dreams">abnormal dreams</span>, <span class="product-label-link" type="condition" conceptid="441417" conceptname="Incoordination">incoordination</span>, <span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">psychosis</span>, <span class="product-label-link" type="condition" conceptid="441838" conceptname="Personality disorder">personality disorder</span>, <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>, <span class="product-label-link" type="condition" conceptid="4181630" conceptname="Choreoathetosis">choreoathetosis</span>, <span class="product-label-link" type="condition" conceptid="439147" conceptname="Amnesia">amnesia</span>, <span class="product-label-link" type="condition" conceptid="438737" conceptname="Acute paranoid reaction">paranoid reaction</span>, <span class="product-label-link" type="condition" conceptid="4131797" conceptname="Disturbance in thinking">abnormal thinking</span>; <span class="Italics">Infrequent:</span> <span class="product-label-link" type="condition" conceptid="4108925" conceptname="Akathisia">akathisia</span>, <span class="product-label-link" type="condition" conceptid="197608" conceptname="Peripheral neuritis in pregnancy">neuropathy</span>, <span class="product-label-link" type="condition" conceptid="373852" conceptname="Neuralgia">neuralgia</span>, <span class="product-label-link" type="condition" conceptid="4208994" conceptname="Increased muscle tone">hypertonia</span>, <span class="product-label-link" type="condition" conceptid="444401" conceptname="Delusions">delusions</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsion</span>, <span class="product-label-link" type="condition" conceptid="4237753" conceptname="Increased libido">libido increased</span>, <span class="product-label-link" type="condition" conceptid="4142453" conceptname="Feeling high">euphoria</span>, <span class="product-label-link" type="condition" conceptid="4078201" conceptname="Mood swings">emotional lability</span>, <span class="product-label-link" type="condition" conceptid="443262" conceptname="Lack or loss of sexual desire">libido decreased</span>, <span class="product-label-link" type="condition" conceptid="439383" conceptname="Vertigo">vertigo</span>, <span class="product-label-link" type="condition" conceptid="441553" conceptname="Myoclonus">myoclonus</span>, <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span>, <span class="product-label-link" type="condition" conceptid="4071366" conceptname="Indifference">apathy</span>, <span class="product-label-link" type="condition" conceptid="440377" conceptname="Paralysis">paralysis</span>, <span class="product-label-link" type="condition" conceptid="444243" conceptname="Neurosis">neurosis</span>, <span class="product-label-link" type="condition" conceptid="4195305" conceptname="Hyperactive behavior">hyperkinesia</span>, <span class="product-label-link" type="condition" conceptid="437584" conceptname="Ataxia">ataxia</span>, <span class="product-label-link" type="condition" conceptid="373995" conceptname="Delirium">acute brain syndrome</span>, <span class="product-label-link" type="condition" conceptid="440814" conceptname="Torticollis">torticollis</span>, <span class="product-label-link" type="condition" conceptid="435785" conceptname="Meningitis">meningitis</span>, <span class="product-label-link" type="condition" conceptid="4333677" conceptname="Mania">manic reaction</span>, <span class="product-label-link" type="condition" conceptid="4195475" conceptname="Behavior showing reduced motor activity">hypokinesia</span>, <span class="product-label-link" type="condition" conceptid="4195585" conceptname="Hostile behavior">hostility</span>, <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>, <span class="product-label-link" type="condition" conceptid="4002033" conceptname="Muscle relaxation">hypotonia</span>; <span class="Italics">Rare:</span> <span class="product-label-link" type="condition" conceptid="4229897" conceptname="Stupor">stupor</span>, <span class="product-label-link" type="condition" conceptid="444252" conceptname="Neuritis">neuritis</span>, <span class="product-label-link" type="condition" conceptid="4154803" conceptname="Raised intracranial pressure">intracranial hypertension</span>, <span class="product-label-link" type="condition" conceptid="374022" conceptname="Hemiplegia">hemiplegia</span>, <span class="product-label-link" type="condition" conceptid="374923" conceptname="Bell's palsy">facial paralysis</span>, <span class="product-label-link" type="condition" conceptid="376690" conceptname="Cerebral edema">brain edema</span>, <span class="product-label-link" type="condition" conceptid="138965" conceptname="Myelitis">myelitis</span>, <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span> and <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span> after abrupt discontinuation.</p>
<p><span class="Bold">Respiratory System</span>—<span class="Italics">Frequent:</span> <span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">rhinitis</span>, <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span>, <span class="product-label-link" type="condition" conceptid="255848" conceptname="Pneumonia">pneumonia</span>, <span class="product-label-link" type="condition" conceptid="4226263" conceptname="Pharyngitis">pharyngitis</span>, <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough increased</span>; <span class="Italics">Infrequent:</span> <span class="product-label-link" type="condition" conceptid="318556" conceptname="Epistaxis">epistaxis</span>, <span class="product-label-link" type="condition" conceptid="194475" conceptname="Hiccoughs">hiccup</span>, <span class="product-label-link" type="condition" conceptid="4283893" conceptname="Sinusitis">sinusitis</span>, <span class="product-label-link" type="condition" conceptid="256451" conceptname="Bronchitis">bronchitis</span>, <span class="product-label-link" type="condition" conceptid="4142495" conceptname="Hypophonia">voice alteration</span>, <span class="product-label-link" type="condition" conceptid="261687" conceptname="Hemoptysis">hemoptysis</span>, <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">lung edema</span>, <span class="product-label-link" type="condition" conceptid="254061" conceptname="Pleural effusion">pleural effusion</span>, <span class="product-label-link" type="condition" conceptid="24969" conceptname="Laryngitis">laryngitis</span>, <span class="product-label-link" type="condition" conceptid="4169883" conceptname="Emphysema">emphysema</span>, <span class="product-label-link" type="condition" conceptid="321689" conceptname="Apnea">apnea</span>, <span class="product-label-link" type="condition" conceptid="316814" conceptname="Hyperventilation">hyperventilation</span>; <span class="Italics">Rare:</span> <span class="product-label-link" type="condition" conceptid="253796" conceptname="Pneumothorax">pneumothorax</span>, <span class="product-label-link" type="condition" conceptid="4197819" conceptname="Fibrosis of lung">lung fibrosis</span>, <span class="product-label-link" type="condition" conceptid="22350" conceptname="Edema of larynx">larynx edema</span>, <span class="product-label-link" type="condition" conceptid="4306572" conceptname="Hypoxia">hypoxia</span>, <span class="product-label-link" type="condition" conceptid="312603" conceptname="Hypoventilation">hypoventilation</span>, <span class="product-label-link" type="condition" conceptid="195958" conceptname="Traumatic pneumohemothorax with open wound into thorax">hemothorax</span>, carcinoma of lung.</p>
<p><span class="Bold">Skin and Appendages System</span>—<span class="Italics">Frequent:</span> <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>; <span class="Italics">Infrequent:</span> <span class="product-label-link" type="condition" conceptid="135030" conceptname="Discoloration of skin">skin discoloration</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span>, <span class="product-label-link" type="condition" conceptid="4262920" conceptname="Skin ulcer">skin ulcer</span>, <span class="product-label-link" type="condition" conceptid="133280" conceptname="Alopecia">alopecia</span>, <span class="product-label-link" type="condition" conceptid="4039266" conceptname="Dry skin">dry skin</span>, skin carcinoma, <span class="product-label-link" type="condition" conceptid="138821" conceptname="Seborrhea">seborrhea</span>, <span class="product-label-link" type="condition" conceptid="134718" conceptname="Hirsutism">hirsutism</span>, herpes simplex, <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">eczema</span>, <span class="product-label-link" type="condition" conceptid="137213" conceptname="Dermal mycosis">fungal dermatitis</span>, <span class="product-label-link" type="condition" conceptid="443943" conceptname="Herpes zoster">herpes zoster</span>; <span class="Italics">Rare:</span> <span class="product-label-link" type="condition" conceptid="4032934" conceptname="Vesiculobullous rash">vesiculobullous rash</span>, <span class="product-label-link" type="condition" conceptid="4042856" conceptname="Fibrous nodule">subcutaneous nodule</span>, <span class="product-label-link" type="condition" conceptid="4042856" conceptname="Fibrous nodule">skin nodule</span>, <span class="product-label-link" type="condition" conceptid="138102" conceptname="Benign neoplasm of skin">skin benign neoplasm</span>, <span class="product-label-link" type="condition" conceptid="4028560" conceptname="Lichenoid dermatitis">lichenoid dermatitis</span>.</p>
<p><span class="Bold">Special Senses System</span>—<span class="Italics">Frequent:</span> <span class="product-label-link" type="condition" conceptid="373786" conceptname="Abnormal vision">abnormal vision</span>, <span class="product-label-link" type="condition" conceptid="373474" conceptname="Diplopia">diplopia</span>; <span class="Italics">Infrequent:</span> <span class="product-label-link" type="condition" conceptid="372328" conceptname="Otitis media">otitis media</span>, <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span>, <span class="product-label-link" type="condition" conceptid="377575" conceptname="Tinnitus">tinnitus</span>, <span class="product-label-link" type="condition" conceptid="377889" conceptname="Hearing loss">deafness</span>, <span class="product-label-link" type="condition" conceptid="436235" conceptname="Taste sense altered">taste perversion</span>, <span class="product-label-link" type="condition" conceptid="380733" conceptname="Otalgia">ear pain</span>, <span class="product-label-link" type="condition" conceptid="379031" conceptname="Pain in eye">eye pain</span>, <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, <span class="product-label-link" type="condition" conceptid="433778" conceptname="Orbital hemorrhage">eye hemorrhage</span>, <span class="product-label-link" type="condition" conceptid="4260194" conceptname="Photophobia">photophobia</span>, <span class="product-label-link" type="condition" conceptid="377286" conceptname="Visual field defect">visual field defect</span>; <span class="Italics">Rare:</span> <span class="product-label-link" type="condition" conceptid="377551" conceptname="Blind hypertensive eye">blindness</span>, <span class="product-label-link" type="condition" conceptid="375545" conceptname="Cataract">cataract</span>, <span class="product-label-link" type="condition" conceptid="378414" conceptname="Retinal detachment">retinal detachment</span>, <span class="product-label-link" type="condition" conceptid="434337" conceptname="Retinal vascular disorder">retinal vascular disorder</span>.</p>
<p><span class="Bold">Urogenital System</span>—<span class="Italics">Frequent:</span> <span class="product-label-link" type="condition" conceptid="81902" conceptname="Urinary tract infectious disease">urinary tract infection</span>, <span class="product-label-link" type="condition" conceptid="4012368" conceptname="Increased frequency of urination">urinary frequency</span>, <span class="product-label-link" type="condition" conceptid="197672" conceptname="Urinary incontinence">urinary incontinence</span>, <span class="product-label-link" type="condition" conceptid="75004" conceptname="Frank hematuria">hematuria</span>, <span class="product-label-link" type="condition" conceptid="194696" conceptname="Dysmenorrhea">dysmenorrhea</span>; <span class="Italics">Infrequent:</span> <span class="product-label-link" type="condition" conceptid="197684" conceptname="Dysuria">dysuria</span>, <span class="product-label-link" type="condition" conceptid="73819" conceptname="Pain of breast">breast pain</span>, <span class="product-label-link" type="condition" conceptid="4302555" conceptname="Menorrhagia">menorrhagia</span>, <span class="product-label-link" type="condition" conceptid="4216771" conceptname="Impotence">impotence</span>, <span class="product-label-link" type="condition" conceptid="195588" conceptname="Cystitis">cystitis</span>, <span class="product-label-link" type="condition" conceptid="192450" conceptname="Retention of urine">urinary retention</span>, abortion, <span class="product-label-link" type="condition" conceptid="4129155" conceptname="Vaginal bleeding">vaginal hemorrhage</span>, <span class="product-label-link" type="condition" conceptid="4081648" conceptname="Acute vaginitis">vaginitis</span>, <span class="product-label-link" type="condition" conceptid="315586" conceptname="Priapism">priapism</span>, <span class="product-label-link" type="condition" conceptid="201620" conceptname="Kidney stone">kidney calculus</span>, <span class="product-label-link" type="condition" conceptid="78804" conceptname="Fibrocystic disease of breast">fibrocystic breast</span>, lactation, <span class="product-label-link" type="condition" conceptid="195876" conceptname="Hematometra">uterine hemorrhage</span>, <span class="product-label-link" type="condition" conceptid="79873" conceptname="Urolith">urolithiasis</span>, <span class="product-label-link" type="condition" conceptid="4338958" conceptname="Salpingitis">salpingitis</span>, <span class="product-label-link" type="condition" conceptid="4167328" conceptname="Pyuria">pyuria</span>, <span class="product-label-link" type="condition" conceptid="195012" conceptname="Intermenstrual bleeding - irregular">metrorrhagia</span>, <span class="product-label-link" type="condition" conceptid="4059477" conceptname="Menopause">menopause</span>, <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">kidney failure</span>, breast carcinoma, cervical carcinoma; <span class="Italics">Rare:</span> <span class="product-label-link" type="condition" conceptid="443800" conceptname="Amenorrhea">amenorrhea</span>, bladder carcinoma, <span class="product-label-link" type="condition" conceptid="80478" conceptname="Engorgement of breasts associated with childbirth">breast engorgement</span>, <span class="product-label-link" type="condition" conceptid="4150043" conceptname="Epididymitis">epididymitis</span>, <span class="product-label-link" type="condition" conceptid="4167354" conceptname="Hypogonadism">hypogonadism</span>, <span class="product-label-link" type="condition" conceptid="195873" conceptname="Leukorrhea">leukorrhea</span>, <span class="product-label-link" type="condition" conceptid="195314" conceptname="Nephrotic syndrome">nephrosis</span>, <span class="product-label-link" type="condition" conceptid="198199" conceptname="Pyelonephritis">pyelonephritis</span>, <span class="product-label-link" type="condition" conceptid="4280509" conceptname="Pain in urethra">urethral pain</span>, <span class="product-label-link" type="condition" conceptid="4057743" conceptname="Hyperuricuria">uricaciduria</span>, <span class="product-label-link" type="condition" conceptid="4161407" conceptname="Withdrawal bleeding">withdrawal bleeding</span>.</p>
<p><span class="Italics">Postintroduction Reports</span>— Voluntary reports of adverse events temporally associated with pergolide that have been received since market introduction and which may have no causal relationship with the drug, include the following: <span class="product-label-link" type="condition" conceptid="379802" conceptname="Neuroleptic malignant syndrome">neuroleptic malignant syndrome</span> and Raynaud’s phenomenon.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-9"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">There is no clinical experience with massive overdosage. The largest <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> involved a young hospitalized adult patient who was not being treated with pergolide but who intentionally took 60 mg of the drug. He experienced <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, and <span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">agitation</span>. Another patient receiving a daily dosage of 7 mg of pergolide unintentionally took 19 mg/day for 3 days, after which his vital signs were normal but he experienced severe <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>. Within 36 hours of resumption of the prescribed dosage level, the <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span> stopped. One patient unintentionally took 14 mg/day for 23 days instead of her prescribed 1.4 mg/day dosage. She experienced severe involuntary movements and <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">tingling</span> in her arms and legs. Another patient who inadvertently received 7 mg instead of the prescribed 0.7 mg experienced <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitations</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, and <span class="product-label-link" type="condition" conceptid="4008580" conceptname="Ventricular bigeminy">ventricular extrasystoles</span>. The highest total daily dose (prescribed for several patients with refractory Parkinson's disease) has exceeded 30 mg.</p>
<p><span class="Italics">Symptoms</span>— Animal studies indicate that the manifestations of overdosage in man might include <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>, decreased blood pressure, and CNS stimulation. The oral median lethal doses in mice and rats were 54 and 15 mg/kg respectively.</p>
<p><span class="Italics">Treatment</span>— To obtain up-to-date information about the treatment of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, a good resource is your certified Regional Poison Control Center. Telephone numbers of certified poison control centers are listed in the <span class="Italics">Physicians’ Desk Reference </span>(PDR). In managing overdosage, consider the possibility of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">multiple drug overdoses</span>, interaction among drugs, and unusual drug kinetics in your patient.</p>
<p>Management of overdosage may require supportive measures to maintain arterial blood pressure. Cardiac function should be monitored; an antiarrhythmic agent may be necessary. If signs of CNS stimulation are present, a phenothiazine or other butyrophenone neuroleptic agent may be indicated; the efficacy of such drugs in reversing the effects of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> has not been assessed.</p>
<p>Protect the patient’s airway and support ventilation and perfusion. Meticulously monitor and maintain, within acceptable limits, the patient’s vital signs, blood gases, serum electrolytes, etc. Absorption of drugs from the gastrointestinal tract may be decreased by giving activated charcoal, which, in many cases, is more effective than <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span> or lavage; consider charcoal instead of or in addition to gastric emptying. Repeated doses of charcoal over time may hasten elimination of some drugs that have been absorbed. Safeguard the patient’s airway when employing gastric emptying or charcoal.</p>
<p>There is no experience with dialysis or hemoperfusion, and these procedures are unlikely to be of benefit.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="A7F1360A-3D0D-49A0-93E8-FD0BEDE6837B"></a><a name="section-10"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Administration of Permax should be initiated with a daily dosage of 0.05 mg for the first 2 days. The dosage should then be gradually increased by 0.1 or 0.15 mg/day every third day over the next 12 days of therapy. The dosage may then be increased by 0.25 mg/day every third day until an optimal therapeutic dosage is achieved.</p>
<p>Permax is usually administered in divided doses 3 times per day. During dosage titration, the dosage of concurrent <span class="Italics">l-</span>dopa/carbidopa may be cautiously decreased.</p>
<p>In clinical studies, the mean therapeutic daily dosage of Permax was 3 mg/day. The average concurrent daily dosage of <span class="Italics">l-</span>dopa/carbidopa (expressed as <span class="Italics">l-</span>dopa) was approximately 650 mg/day. The efficacy of Permax at doses above 5 mg/day has not been systematically evaluated.  Doses of pergolide above 5 mg/day are not recommended (<span class="Italics">see</span><a href="#A8396953-1EDB-4930-9CD1-54ADF1856B41">WARNINGS</a>).</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-11"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Tablets (modified rectangle shape, scored):</p>
<p>0.05 mg, ivory, debossed with A 024, in bottles of 30 (UC5336) — NDC 0187-0839-01</p>
<p>0.25 mg, green, debossed with A 025, in bottles of 100 (UC5337) — NDC 0187-0840-02</p>
<p>1 mg, pink, debossed with A 026, in bottles of 100 (UC5338) — NDC 0187-0841-02</p>
<p>Store at 25°C (77°F); excursions permitted to 15°C-30°C (59°F-86°F) [see USP Controlled Room Temperature].</p>
<p>PERMAX is a registered trademark of Eli Lilly and Company, and licensed in the US to Valeant Pharmaceuticals International.</p>
<p><span class="Bold">Literature revised August 18, 2004</span></p>
<p><span class="Bold">Manufactured for:</span><span class="Bold"><br></span><span class="Bold">Valeant Pharmaceuticals International</span><span class="Bold"><br></span><span class="Bold">3300 Hyland Ave.</span><span class="Bold"><br></span><span class="Bold">Costa Mesa, CA 92626 U.S.A.</span></p>
<p><span class="Bold">Part Number 3083900EX00</span><span class="Bold"><br></span><span class="Bold">PRINTED IN USA</span></p>
<p></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>PERMAX 		
					</strong><br><span class="contentTableReg">pergolide tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0187-0839</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>pergolide</strong> (pergolide) </td>
<td class="formItem"></td>
<td class="formItem">0.05 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>croscarmellose sodium</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>iron oxide</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>lactose</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>magnesium stearate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>povidone</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>L-methionine</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE (ivory) </td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">RECTANGLE</td>
<td class="formLabel">Size</td>
<td class="formItem">12mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">A;024</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Coating</td>
<td class="formItem">false</td>
<td class="formLabel">Symbol</td>
<td class="formItem">false</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0187-0839-01</td>
<td class="formItem">30  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>PERMAX 		
					</strong><br><span class="contentTableReg">pergolide tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0187-0840</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>pergolide</strong> (pergolide) </td>
<td class="formItem"></td>
<td class="formItem">0.25 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>croscarmellose sodium</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>iron oxide</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>lactose</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>magnesium stearate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>povidone</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>FD&amp;C Blue No. 2</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">GREEN</td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">RECTANGLE</td>
<td class="formLabel">Size</td>
<td class="formItem">12mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">A;025</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Coating</td>
<td class="formItem">false</td>
<td class="formLabel">Symbol</td>
<td class="formItem">false</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0187-0840-02</td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>PERMAX 		
					</strong><br><span class="contentTableReg">pergolide tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0187-0841</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>pergolide</strong> (pergolide) </td>
<td class="formItem"></td>
<td class="formItem">1 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>croscarmellose sodium</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>iron oxide</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>lactose</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>magnesium stearate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>povidone</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">PINK</td>
<td class="formLabel">Score</td>
<td class="formItem">2 pieces</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">RECTANGLE</td>
<td class="formLabel">Size</td>
<td class="formItem">12mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">A;026</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Coating</td>
<td class="formItem">false</td>
<td class="formLabel">Symbol</td>
<td class="formItem">false</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0187-0841-02</td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Valeant Pharmaceuticals, Inc.</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 3/2007<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>4F7E4B2C-8485-957D-1924-34091C0A3682</div>
<div>Set id: A26390E8-EB86-4623-8CDD-45B24B14DF74</div>
<div>Version: 1</div>
<div>Effective Time: 20070330</div>
</div>
</div> <div class="DistributorName">Valeant Pharmaceuticals, Inc.</div></p>
</body></html>
